Skip to content
  • .home
  • .business & economy
  • .tech
  • .ledger of lies

Corruption Ledger

The Public Ledger of Corruption

  • about
  • .corruption
    • banks
    • censorship
    • corporate
    • environment
    • government
    • health
    • journalism
    • misinformation
  • .crime
    • child victims
    • tech crime
    • dimwit crimes
    • financial crime
    • killings
    • shootings
  • .international conflict
    • Israel-Palestine
    • Nordstream
    • Russia vs. West
    • war news
    • war machines
  • .privacy & surveillance
  • .leaks
    • all leaks
    • Wikileaks
  • .regions
    • All Regions
    • Africas
    • North Americas
      • All
      • Canada
      • U.S.
    • Asias
    • Europe
    • Middle East
    • Oceania
  • Toggle search form
  • Polish minister launches bill to extradite Ukrainian Nazi WW2 veteran Hunka from Canada All News
  • Poland: Ukraine is drowning and therefore dangerous All News
  • This China trade war isn’t about semiconductors: Straits Times Business & Economy
  • Airbus Hacker Threatens to Sell US, Europe Military Intel on Dark Web All News
  • Intel-linked UK official pushing censorship of Russell Brand -The Grayzone _enforcement
  • Australia Signs $210 Million Underwater Tracking Contract All News
  • TransUnion denies it was hacked, links leaked data to 3rd party All News
  • 400,000 calls made to Japanese Embassy in China over radioactive water All News

Mifepristone: Will a court overturn abortion drug’s approval?

Posted on April 21, 2023July 3, 2023 By 5amResearch No Comments on Mifepristone: Will a court overturn abortion drug’s approval?

I’m going to write about mifepristone and the legal troubles around it, and I will probably regret doing so. That’s partly because the situation is changing – this dispute is now before the US supreme court, and for better or worse, they will have the last word. But as of this writing, that last word hasn’t been handed down, and it’s unclear when it will be (although it should be soon).
Another reason to regret taking up the topic is that it’s a tangle of regulatory law and politics, and I have never enjoyed the smell of that combination in the oven. First, the chemistry and biology to take refuge in: as readers will likely know, mifepristone is a progesterone receptor ligand, at least in this use. Blocking the progesterone pathway causes the mucosal lining of the uterus to degenerate, and a follow-up dose of the prostaglandin misoprostol accelerates that lining being shed. The combination is highly effective for ending a pregnancy within the first two months.
And that, of course, is where the trouble lies. Many people oppose abortion for religious and various other reasons. The English writer Samuel Johnson, while visiting Scotland, said he did not inquire about the methods used to produce Scotch whiskey because he did not wish to know more about the art of making poison pleasant. Well, to an abortion opponent, mifepristone makes murder convenient. I don’t share that view, but that’s as succinctly as I think it can be stated. Those on the other side of the issue do not regard a developing embryo that young as an actual human being yet, and say that decisions about the mother’s bodily functions belong with the mother.

There’s enough regulatory uncertainty already, and letting every federal judge take a swing at therapies they dislike is exactly what we don’t need.

The two drug combination was approved in the US in 2000, and has been used millions of times since then. That use has steadily increased, as the drug has been made more easily available over the years. The latest move, during the pandemic, was to approve its dispensing by mail-order pharmacies, and that is a key part of the latest challenge. There is an 1873 US law that prohibits sending drugs or devices to induce abortion through the mail, and although much else has been altered in that statute, that language has not. The legal office of the US Postal Service (USPS) weighed in on this last December, saying that the 1873 act was written to prevent illegal activity, but since then abortion has become legal (although this is currently being fought out state by state after the 1973 Roe v Wade supreme court ruling protecting women’s rights to an abortion was overturned in 2022). Moreover, the drug combination itself is, of course, legal, since it was approved by the Food and Drug Administration (FDA). Therefore, says the USPS, this provision does not apply.
The anti-abortion groups who brought the latest suit disagree, as you might imagine. They also say that the FDA approval was mishandled from the start (and in the years since, as restrictions have eased). The 1873 law applies, they say, and the drug combination is in fact illegal since (in their view) the FDA violated its own rules while regulating it. A federal judge in Texas agreed with this reasoning – loudly and wholeheartedly, if you read his decision – and basically overruled the 2000 drug approval. Meanwhile, a federal judge in Washington state almost simultaneously ordered the FDA not to do anything to the availability of the drug while such cases were before the courts.
Thus the legal appeals, which are before the supreme court as I write. There are several issues here: does the 1873 law still apply? Was the FDA’s original approval valid? If so, then are the later eased access requirements themselves valid? And can a federal judge step in and overrule a regulatory agency’s drug approval in the first place? No one has ever tried, and the very thought that this might become common makes almost everyone in the biopharma business feel ill. There’s enough regulatory uncertainty in this line of work already, thanks ever so much, and letting every federal judge take a swing at therapies that they find a reason to dislike is exactly what we don’t need.
My own guess is that the supreme court will do what it often tries to – tiptoe through with as narrow a ruling as possible while dodging the larger issues. But they don’t (or can’t) always do that, and this could be one of the exceptions. We can only wait. What a mess, though. What a terrible mess.

Related

enforcement archive, health, Ledger of Lies, Misinformation, z-Exclude Tags:All Regions, Corruption, Region Americas, Region US, z.chemistryworld

Post navigation

Previous Post: Royal Society of Chemistry partners with ResearchGate to promote open access
Next Post: Companies Doing Business with US Gov – Supreme Court and False Claims Act (FCA) Knowledge Requirements

You must log in to post a comment.

Wall of Shame

  • Censorship & Access to Information
  • Environmental Collapse
  • Journalism
  • In Court
  • Enforcement
  • Free Speech: What’s it good for?

Recent

  • Polish minister launches bill to extradite Ukrainian Nazi WW2 veteran Hunka from Canada
  • Poland: Ukraine is drowning and therefore dangerous
  • This China trade war isn’t about semiconductors: Straits Times
  • Airbus Hacker Threatens to Sell US, Europe Military Intel on Dark Web
  • Intel-linked UK official pushing censorship of Russell Brand -The Grayzone
  • Australia Signs $210 Million Underwater Tracking Contract
  • TransUnion denies it was hacked, links leaked data to 3rd party
  • 400,000 calls made to Japanese Embassy in China over radioactive water
  • Tornado at Pfizer plant accentuates US drug shortage issues
  • UK intelligence spun 2013 Syria chemical attack, leaked docs show
About CL
Shootings | Air Force and Aerospace
Rumble Video from CL
  • Amid a child labor crisis, U.S. state governments are loosening regulations corporate corruption
  • GoodRx to Pay $1.5 Million in First Ever FTC Health Breach Notification Rule Enforcement Action Compliance Regulation
  • Hong Kong mortgage frenzy sees banks go big on cash handouts All News
  • Russian court rejects WSJ journalist’s latest appeal, to remain in prison until August 30 All News
  • Update: UK Government announces new Russia sanctions International Conflict
  • Tennessee State Senator Pleads Guilty to Campaign Finance Scheme corporate corruption

Copyright © 2022 Corruption Ledger. This web site contains no ads.